BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11831900)

  • 1. Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV.
    Kim CY; Whittington DA; Chang JS; Liao J; May JA; Christianson DW
    J Med Chem; 2002 Feb; 45(4):888-93. PubMed ID: 11831900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of murine carbonic anhydrase IV and human carbonic anhydrase II complexed with brinzolamide: molecular basis of isozyme-drug discrimination.
    Stams T; Chen Y; Boriack-Sjodin PA; Hurt JD; Liao J; May JA; Dean T; Laipis P; Silverman DN; Christianson DW
    Protein Sci; 1998 Mar; 7(3):556-63. PubMed ID: 9541386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quaternary ammonium substituted thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides: Potential membrane-impermeable inhibitors of carbonic anhydrase.
    May JA; Namil A; Chen HH; Dantanarayana AP; Dupré B; Liao JC
    Bioorg Med Chem; 2006 Mar; 14(6):2052-9. PubMed ID: 16297631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with "two-prong" inhibitors reveal the molecular basis of high affinity.
    Jude KM; Banerjee AL; Haldar MK; Manokaran S; Roy B; Mallik S; Srivastava DK; Christianson DW
    J Am Chem Soc; 2006 Mar; 128(9):3011-8. PubMed ID: 16506782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes.
    Deeb O; Goodarzi M; Khadikar PV
    Chem Biol Drug Des; 2012 Apr; 79(4):514-22. PubMed ID: 22181786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
    Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors.
    Poli G; Jha V; Martinelli A; Supuran CT; Tuccinardi T
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29937490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of inhibitor binding to human carbonic anhydrase II.
    Boriack-Sjodin PA; Zeitlin S; Chen HH; Crenshaw L; Gross S; Dantanarayana A; Delgado P; May JA; Dean T; Christianson DW
    Protein Sci; 1998 Dec; 7(12):2483-9. PubMed ID: 9865942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glaucoma and the applications of carbonic anhydrase inhibitors.
    Scozzafava A; Supuran CT
    Subcell Biochem; 2014; 75():349-59. PubMed ID: 24146387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Wang ZC; Qin YJ; Wang PF; Yang YA; Wen Q; Zhang X; Qiu HY; Duan YT; Wang YT; Sang YL; Zhu HL
    Eur J Med Chem; 2013 Aug; 66():1-11. PubMed ID: 23777898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents.
    Chiaramonte N; Bua S; Ferraroni M; Nocentini A; Bonardi A; Bartolucci G; Durante M; Lucarini L; Chiapponi D; Dei S; Manetti D; Teodori E; Gratteri P; Masini E; Supuran CT; Romanelli MN
    Eur J Med Chem; 2018 May; 151():363-375. PubMed ID: 29635168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
    Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
    Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal Fertility Requires the Expression of Carbonic Anhydrases II and IV in Sperm.
    Wandernoth PM; Mannowetz N; Szczyrba J; Grannemann L; Wolf A; Becker HM; Sly WS; Wennemuth G
    J Biol Chem; 2015 Dec; 290(49):29202-16. PubMed ID: 26487715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport activity of the high-affinity monocarboxylate transporter MCT2 is enhanced by extracellular carbonic anhydrase IV but not by intracellular carbonic anhydrase II.
    Klier M; Schüler C; Halestrap AP; Sly WS; Deitmer JW; Becker HM
    J Biol Chem; 2011 Aug; 286(31):27781-91. PubMed ID: 21680735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative structure-activity relationship study on some aromatic/heterocyclic sulfonamides and their charged derivatives acting as carbonic anhydrase inhibitors.
    Gupta SP; Kumaran S
    J Enzyme Inhib Med Chem; 2005 Jun; 20(3):251-9. PubMed ID: 16119196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue.
    Winum JY; Temperini C; El Cheikh K; Innocenti A; Vullo D; Ciattini S; Montero JL; Scozzafava A; Supuran CT
    J Med Chem; 2006 Nov; 49(24):7024-31. PubMed ID: 17125255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: role of hydrogen-bonding networks in ligand binding and drug design.
    Abbate F; Supuran CT; Scozzafava A; Orioli P; Stubbs MT; Klebe G
    J Med Chem; 2002 Aug; 45(17):3583-7. PubMed ID: 12166931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Combined Crystallographic and Theoretical Study Explains the Capability of Carboxylic Acids to Adopt Multiple Binding Modes in the Active Site of Carbonic Anhydrases.
    Langella E; D'Ambrosio K; D'Ascenzio M; Carradori S; Monti SM; Supuran CT; De Simone G
    Chemistry; 2016 Jan; 22(1):97-100. PubMed ID: 26507456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.
    Sūdžius J; Baranauskienė L; Golovenko D; Matulienė J; Michailovienė V; Torresan J; Jachno J; Sukackaitė R; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2010 Nov; 18(21):7413-21. PubMed ID: 20889345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the inhibition mechanism of cytosolic versus transmembrane carbonic anhydrases by ESR.
    Ciani L; Cecchi A; Temperini C; Supuran CT; Ristori S
    J Phys Chem B; 2009 Oct; 113(42):13998-4005. PubMed ID: 19778001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.